Insider Stock Trading History of Boyd Thomas A


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Boyd Thomas A since year 2005. The trader's CIK number is 1327433. At the time of this reporting, Boyd Thomas A is the Sr. VP, Product Dev. of Progenics Pharmaceuticals Inc . (stock ticker symbol PGNX). See this page for all insider trading activities at Progenics Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Boyd Thomas A since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2010-07-01 PGNX Progenics Pharmaceuticals Inc Option Ex 2,675 4.44 11,877
2010-06-22 PGNX Progenics Pharmaceuticals Inc Sale 2,409 5.74 13,818
2010-04-01 PGNX Progenics Pharmaceuticals Inc Option Ex 2,621 4.56 11,941
2010-04-01 PGNX Progenics Pharmaceuticals Inc Option Ex 2,621 4.56 11,941
2010-01-04 PGNX Progenics Pharmaceuticals Inc Option Ex 3,147 3.78 11,905
2009-10-01 PGNX Progenics Pharmaceuticals Inc Option Ex 2,666 4.26 11,354
2009-07-01 PGNX Progenics Pharmaceuticals Inc Option Ex 7,738 5.33 41,243
2009-06-23 PGNX Progenics Pharmaceuticals Inc Sale 2,000 4.73 9,468
2009-04-01 PGNX Progenics Pharmaceuticals Inc Option Ex 2,120 5.65 11,978
2009-01-02 PGNX Progenics Pharmaceuticals Inc Option Ex 1,355 9.13 12,371
2008-10-01 PGNX Progenics Pharmaceuticals Inc Option Ex 4,384 6.53 28,627
2008-10-01 PGNX Progenics Pharmaceuticals Inc Option Ex 4,384 6.53 28,627
2008-07-01 PGNX Progenics Pharmaceuticals Inc Option Ex 2,921 13.64 39,842
2008-04-01 PGNX Progenics Pharmaceuticals Inc Option Ex 1,914 6.52 12,479
2008-01-02 PGNX Progenics Pharmaceuticals Inc Option Ex 692 15.33 10,608
2007-10-01 PGNX Progenics Pharmaceuticals Inc Option Ex 2,029 19.03 38,611
2007-10-01 PGNX Progenics Pharmaceuticals Inc Option Ex 2,029 19.03 38,611
2007-08-15 PGNX Progenics Pharmaceuticals Inc Option Ex 2,000 15.41 30,814
2007-08-15 PGNX Progenics Pharmaceuticals Inc Sale 2,000 22.88 45,766
2007-07-16 PGNX Progenics Pharmaceuticals Inc Sale 2,000 21.51 43,018
2007-07-16 PGNX Progenics Pharmaceuticals Inc Option Ex 2,000 15.41 30,814
2007-07-02 PGNX Progenics Pharmaceuticals Inc Option Ex 545 18.71 10,196
2007-06-15 PGNX Progenics Pharmaceuticals Inc Option Ex 2,000 15.41 30,814
2007-06-15 PGNX Progenics Pharmaceuticals Inc Sale 2,000 22.03 44,054
2007-05-15 PGNX Progenics Pharmaceuticals Inc Option Ex 2,000 15.41 30,814
2007-05-15 PGNX Progenics Pharmaceuticals Inc Sale 2,000 21.90 43,804
2007-04-16 PGNX Progenics Pharmaceuticals Inc Sale 2,000 26.94 53,874
2007-04-16 PGNX Progenics Pharmaceuticals Inc Option Ex 2,000 15.41 30,814
2007-04-16 PGNX Progenics Pharmaceuticals Inc Sale 2,000 26.94 53,874
2007-04-16 PGNX Progenics Pharmaceuticals Inc Option Ex 2,000 15.41 30,814
2007-04-02 PGNX Progenics Pharmaceuticals Inc Option Ex 2,018 20.13 40,622
2007-03-15 PGNX Progenics Pharmaceuticals Inc Option Ex 2,000 15.41 30,814
2007-03-15 PGNX Progenics Pharmaceuticals Inc Sale 2,000 22.78 45,568
2007-02-15 PGNX Progenics Pharmaceuticals Inc Option Ex 4,000 17.19 68,760
2007-02-15 PGNX Progenics Pharmaceuticals Inc Sale 4,000 29.97 119,896
2007-01-03 PGNX Progenics Pharmaceuticals Inc Option Ex 428 21.88 9,364
2006-12-15 PGNX Progenics Pharmaceuticals Inc Option Ex 2,000 17.19 34,380
2006-12-15 PGNX Progenics Pharmaceuticals Inc Sale 2,000 26.05 52,100
2006-11-15 PGNX Progenics Pharmaceuticals Inc Option Ex 2,000 15.41 30,814
2006-11-15 PGNX Progenics Pharmaceuticals Inc Sale 2,000 28.93 57,856
2006-10-02 PGNX Progenics Pharmaceuticals Inc Option Ex 470 19.58 9,202
2006-07-03 PGNX Progenics Pharmaceuticals Inc Option Ex 1,986 20.45 40,615
2006-06-21 PGNX Progenics Pharmaceuticals Inc Sale 3,750 21.64 81,138
2006-04-03 PGNX Progenics Pharmaceuticals Inc Option Ex 376 21.77 8,185
2006-02-15 PGNX Progenics Pharmaceuticals Inc Option Ex 10,000 13.62 136,250
2006-02-15 PGNX Progenics Pharmaceuticals Inc Sale 10,000 28.00 280,000
2006-01-03 PGNX Progenics Pharmaceuticals Inc Option Ex 367 20.86 7,655
2005-06-20 PGNX Progenics Pharmaceuticals Inc Sale 750 19.85 14,887

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Boyd Thomas A (Sr. VP, Product Dev. of Progenics Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.